Throughout the last three months, 7 analysts have evaluated GoodRx Holdings (NASDAQ:GDRX), offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
5
1
0
0
Last 30D
0
0
1
0
0
1M Ago
1
3
0
0
0
2M Ago
0
0
0
0
0
3M Ago
0
2
0
0
0
In the assessment of 12-month price targets, analysts unveil insights for GoodRx Holdings, presenting an average target of $10.64, a high estimate of $16.00, and a low estimate of $9.00. Witnessing a positive shift, the current average has risen by 12.0% from the previous average price target of $9.50.
Analyzing Analyst Ratings: A Detailed Breakdown
A clear picture of GoodRx Holdings's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
Craig Hettenbach
Morgan Stanley
Raises
Equal-Weight
$9.50
$7.00
Mark Mahaney
RBC Capital
Raises
Outperform
$10.00
$8.00
Stephanie Davis
Barclays
Raises
Overweight
$10.00
$9.00
John Ransom
Raymond James
Announces
Outperform
$10.00
-
Charles Rhyee
TD Cowen
Raises
Buy
$16.00
$14.00
Scott Schoenhaus
Keybanc
Announces
Overweight
$9.00
-
Stan Berenshteyn
Wells Fargo
Announces
Overweight
$10.00
-
Key Insights:
Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects ...Full story available on Benzinga.com
Benzinga